1Shepherd FA, Dancey J, Ramlau R, et al. Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously, treated with platinum-based chemotherapy[J]. J Clin Oncol 2000, 18(10) : 2095-2103.
2Fossella FV, DeVore R, Kerr RN, et al. Randomized Phase Ⅲ trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens[J ]. J Clin Oncol, 2000,18(12) : 2354-2357.
3Gridelli C, Gallo C, DiMaio M, et al. A randomised clinical trial of two docetaxel regimens ( weekly vs 3 week) in the second lineof non-small-cell lung cancer. The DISTAK 01 studay[ J ]. Br J Cancer, 2004, 91 (12) : 1996-2004.
4Schiller J, Harrington D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer[J]. N Engl J Med, 2002, 346(2): 92-98.
5Davies A, Lara PN, Mack PC,et al. Docetaxel in non-small-cell lung cancer: a review [J]. Expert Opin Pharmacother, 2003, 4( 4 ) : 553-565.
6Fossella F, Pereira JR, yon Pawel J, et al. Randomized, multinational, phase Ⅲ study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer : the TAX 326 study group[J]. J Clin Oncol, 2003, 21(16) : 3016-3024.
7Marino P,Pampallona S,Preatoni A,et al.Chemotherapy vs supportive care in advanced non-small-cell lung cancer:results of a meta-analysis of the literature.Chest,1994,106 (3):861-865.
8Bonomi P,Kim K,Fairclough D,et al.Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin:results of an Eastern Cooperative Oncology Group trial.J Clin Oncol,2000,18 (3):623-631.
9Cardenal F,Lopez-Cabrerizo MP,Anton A,et al.Randomized phase Ⅲ study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer.J Clin Oncol,1999,17(1):12-18.
10Belani CP,Eckardt J.Development of docetaxel in advanced nonsmall-cell lung cancer.Lung Cancer,2004,46 (Suppl 2):3-11.
